BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21397039)

  • 1. Mining microarray data to predict the histological grade of a breast cancer.
    Fabregue M; Bringay S; Poncelet P; Teisseire M; Orsetti B
    J Biomed Inform; 2011 Dec; 44 Suppl 1():S12-S16. PubMed ID: 21397039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
    Colombo PE; Milanezi F; Weigelt B; Reis-Filho JS
    Breast Cancer Res; 2011 Jun; 13(3):212. PubMed ID: 21787441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
    Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering novelty in sequential patterns: application for analysis of microarray data on Alzheimer disease.
    Bringay S; Roche M; Teisseire M; Poncelet P; Abdel Rassoul R; Verdier JM; Devau G
    Stud Health Technol Inform; 2010; 160(Pt 2):1314-8. PubMed ID: 20841897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting features of breast cancer with gene expression patterns.
    Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
    Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimised gene selection approach using wavelet power spectrum.
    Prabakaran S; Sahu R; Verma S
    Int J Bioinform Res Appl; 2011; 7(4):335-54. PubMed ID: 22112527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer.
    Amiri Souri E; Chenoweth A; Cheung A; Karagiannis SN; Tsoka S
    Br J Cancer; 2021 Aug; 125(5):748-758. PubMed ID: 34131308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for assigning genomic grade to individual breast tumours.
    Wennmalm K; Bergh J
    BMC Cancer; 2011 Jul; 11():306. PubMed ID: 21777443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genes.
    Tsumagari K; Chijiiwa K; Nagai H; Makita M; Kasumi F; Akiyama F; Sakamoto G; Miki Y
    Breast Cancer; 2005; 12(3):166-77. PubMed ID: 16110286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Software development in data analysis and mining for cDNA microarray].
    Wu B; Wang J; Wang M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Dec; 24(6):1394-7. PubMed ID: 18232501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray technology and its effect on breast cancer (re)classification and prediction of outcome.
    Cardoso F
    Breast Cancer Res; 2003; 5(6):303-4. PubMed ID: 14580246
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
    Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular classification of breast carcinomas using tissue microarrays.
    Callagy G; Cattaneo E; Daigo Y; Happerfield L; Bobrow LG; Pharoah PD; Caldas C
    Diagn Mol Pathol; 2003 Mar; 12(1):27-34. PubMed ID: 12605033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling using cDNA microarrays.
    Jones C; Simpson P; Mackay A; Lakhani SR
    Methods Mol Med; 2006; 120():403-14. PubMed ID: 16491614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
    Morais-Rodrigues F; Silv Erio-Machado R; Kato RB; Rodrigues DLN; Valdez-Baez J; Fonseca V; San EJ; Gomes LGR; Dos Santos RG; Vinicius Canário Viana M; da Cruz Ferraz Dutra J; Teixeira Dornelles Parise M; Parise D; Campos FF; de Souza SJ; Ortega JM; Barh D; Ghosh P; Azevedo VAC; Dos Santos MA
    Gene; 2020 Feb; 726():144168. PubMed ID: 31759986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
    Bertucci F; Viens P; Birnbaum D
    Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating breast cancer genetics into clinical practice.
    Mukherjee A; Rakha EA
    Womens Health (Lond); 2012 Jan; 8(1):99-112. PubMed ID: 22171779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.